Status:
COMPLETED
Four Dimensions in Schizophrenia
Lead Sponsor:
AstraZeneca
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Brief Summary
Observational, non-interventional, longitudinal, prospective,multicenter, open label (No treatment is involved). 4 assessment will be carried out , in months 0, 1, 3 and 6. The primary objective is to...
Eligibility Criteria
Inclusion
- Provision of written inform consent
- Diagnosed of Schizophrenia of Schizoaffective Disorder based on DSM-IV-TR
- With an acute episode or worsening of clinical status. Defined as change in clinical status that need a significant change in therapeutic plan.
- Able to understand and comply with requirements of the study
Exclusion
- Mental retardation
- Unstable somatic disease, that is not receiving adequate treatment, based on investigator opinion.
- To have been recruited in a clinical trial in the last 4 weeks
- To have planned the inclusion in a clinical trial during the follow-up of this study
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT00782899
Start Date
October 1 2008
End Date
September 1 2009
Last Update
December 10 2010
Active Locations (65)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Vitoria-Gasteiz, Alava, Spain
2
Research Site
Almansa, Albacete, Spain
3
Research Site
Alcoy, Alicante, Spain
4
Research Site
Alicante, Alicante, Spain